Cytogenetic abnormalities in hematologic neoplasms with germline predisposition.
Cytogenetic abnormalities
Genetic rescue
Germline predisposition
Hematologic neoplasms
Monosomy 7
Journal
Current research in translational medicine
ISSN: 2452-3186
Titre abrégé: Curr Res Transl Med
Pays: France
ID NLM: 101681234
Informations de publication
Date de publication:
20 Oct 2023
20 Oct 2023
Historique:
received:
05
07
2023
revised:
21
09
2023
accepted:
29
09
2023
medline:
22
10
2023
pubmed:
22
10
2023
entrez:
22
10
2023
Statut:
aheadofprint
Résumé
The number of predisposing genes is continuously growing with the widespread availability of DNA sequencing, increasing the prevalence of hematologic malignancies with germline predisposition. Cytogenetic analyses provide an effective approach for the recognition of these malignancies with germline predisposition, which is critical for proper diagnosis, optimal treatment and genetic counseling. Based on the World Health Organization and the international consensus classifications as well as the European LeukemiaNet recommendations, this review first presents an advanced classification of neoplasms with germline predisposition focused on the acquired cytogenetic alterations during leukemogenesis. The various genetic rescue mechanisms and the progression to transformation are then explained. The review also outlines the specific constitutional and somatic cytogenetic aberrations indicative of germline predisposition disorders in B-acute lymphoblastic leukemia (ALL), T-ALL, bone marrow failure syndrome and myeloid neoplasms. An emphasis is made on monosomy 7 in the predisposition field, its frequency and diagnosis impact as well as its various circumstances of occurrence. Lastly, we propose cytogenetic technical recommendations and guidelines for clinical reporting of these specific aberrations.
Identifiants
pubmed: 37865978
pii: S2452-3186(23)00040-5
doi: 10.1016/j.retram.2023.103416
pii:
doi:
Types de publication
Practice Guideline
Langues
eng
Sous-ensembles de citation
IM
Pagination
103416Informations de copyright
Copyright © 2023. Published by Elsevier Masson SAS.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Undeclared.